Costello, Shawn M. http://orcid.org/0000-0003-3926-8074
Shoemaker, Sophie R.
Hobbs, Helen T. http://orcid.org/0000-0002-4789-0608
Nguyen, Annalee W. http://orcid.org/0000-0003-1268-7164
Hsieh, Ching-Lin http://orcid.org/0000-0002-3665-5717
Maynard, Jennifer A. http://orcid.org/0000-0002-0363-8486
McLellan, Jason S. http://orcid.org/0000-0003-3991-542X
Pak, John E.
Marqusee, Susan http://orcid.org/0000-0001-7648-2163
Article History
Received: 4 August 2021
Accepted: 21 January 2022
First Online: 2 March 2022
Competing interests
: S. M. C., S. R. S., and S. M. are inventors on U.S. patent application no. 63/220,388, (Methods related to an alternative conformation of the SARS-CoV-2 Spike Protein). A. W. N., C.-L. H., J. S. M., and J. A. M. are inventors on U.S. patent application no. 63/135,913 (Cross-reactive antibodies recognizing the coronavirus spike S2 domain). J. S. M. is an inventor on U.S. patent application no. 62/412,703 (Prefusion coronavirus spike proteins and their use). C.-L. H., J. A. M. and J. S. M. are inventors on U.S. patent application no. 63/032,502 (Engineered coronavirus spike (S) protein and methods of use thereof).
Free to read: This content has been made available to all.